Adrenocorticotropin hormone stimulates interleukin-18 expression in human HaCaT keratinocytes

Journal of Investigative Dermatology

Volumn 127, Issue 5, 2007, Pages 1210-1216

  Park, Hyun Jeong ^a   Kim, Hee Jung ^a   Lee, Jun Young ^a   Cho, Baik Kee ^a   Gallo, Richard L ^b,c   Cho, Dae Ho ^d  

^a The Catholic University of Korea   (South Korea)

^b San Diego   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 1 INHIBITOR; CASPASE INHIBITOR; CORTICOTROPIN; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; SKIN;

ADRENOCORTICOTROPIC HORMONE; CASPASE 1; CELL LINE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; INTERLEUKIN-18; KERATINOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTORS, PITUITARY HORMONE; RNA, MESSENGER;

EID: 34247228610     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700703     Document Type: Article

References (36)

1. Bohm M, Luger TA, Tobin DJ, Garcia-Borron JC (2006) Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 126:1966-75
2. Chakraborty AK, Funasaka Y, Slominski A, Emak G, Hwang J, Pawelek JM et al. (1996) Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1313:130-8
3. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immunemediated inflammation. N Engl J Med 332:1351-62
4. Conti B, Sugama S, Kim Y, Tinti C, Kim H, Baker H et al. (2000) Modulation of IL-18 production in the adrenal cortex following acute ACTH or chronic corticosterone treatment. Neuroimmunomodulation 8:1-7
5. Dinarello CA (1999) IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103:11-24
6. Dugue B, Leppanen EA, Teppo AM, Fyhrquist F, Grasbeck R (1993) Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumor necrosis factor alpha, antidiuretic hormone and serum cortisol. J Clin Lab Invest 53:555-61
7. Ghayur T, Banerjee S, Banerjee MD, Herzog L, Herzog A, Quintral L et al. (1997) Caspase-1 processed IFN-γ- inducing factor and regulates LPS-induced IFN-γ production. Nature 386:619-23
8. Gu Y, Kida K, Tsutsui H, Ku G, Hsiao K, Fleming MA et al. (1997) Activation of interferon-γ- inducing factor mediated by interleukin-1β converting enzyme. Science 275:206-9
9. Hoshino T, Wiltrout RH, Young HA (1999) IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 162:5070-7
10. Luger TA, Scholzen T, Brzoska T, Becher E, Slominski A, Paus R (1998) Cutaneous immunomodulation and coordination of skin responses by alpha-melanocyte-stimulating hormone. Ann NY Acad Sci 840:381-94
11. Mee JB, Alam Y, Groves RW (2000) Human keratinocytes constitutively produce but do not process interleukin-18. Br J Dermatol 143:330-6
12. Naik SM, Cannon G, Burbach GJ, Singh SR, Swerlick RA, Wilcox JN et al. (1999) Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. J Invest Dermatol 113:766-72
13. Nakanishi K, Yoshimoto T, Txutsui H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Ann Rev Immunol 19:423-74
14. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman A (1991) Interleukin-1β and -6 stimulate the release of corticotrophin releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128:37-44
15. Ohta Y, Hamada Y, Katsuoka K (2001) Expression of IL-18 in psoriasis. Arch Dermatol Res 293:334-42
16. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T et al. (1995) Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88-91
17. Park HJ, Kim HJ, Lee JY, Cho BK, Kang SJ, Kang H et al. (2005) Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. J Invest Dermatol 124:751-5
18. Pavey S, Gabrielli B (2002) Alpha-melanocyte stimulating hormone potentiates p16/CDKN2A expression in human skin after ultraviolet irradiation. Cancer Res 62:875-80
19. Schotte P, Schauvliege R, Janssens S, Beyaert R (2001) The cathepsin B inhibitor z-FA.fmk inhibits cytokine production in macrophages stimulated by lipopolysaccharide. J Biol Chem 276:21153-7
20. Sekiyama A, Useda H, Kashiwamura S, Sekiyama R, Takeda M, Rokutan K et al. (2005) A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. Immunity 22:669-77
21. Slominski A, Ermak G, Hwang J, Chakraborty A, Mazurkiewicz JE, Mihm M (1995) Proopiomelanocortin, corticotropin releasing hormone and corticotrophin releasing hormone receptor genes are expressed in human skin. FEBS Lett 374:113-6
22. Slominski A, Mihm MC (1996) Potential mechanism of skin response to stress. Int J Dermatol 35:849-51
23. Slominski A, Paus R, Wortsman J (1993) On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 93:C1-6
24. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J (2004a) Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145:941-50
25. Slominski A, Szczesniewski A, Wortsman J (2000a) Liquid chromatographymass spectrometry detection of corticotropin-releasing hormone and proopio-melanocortin-derived peptides in human skin. J Clin Endocrinol Metab 85:3582-8
26. Slominski A, Wortsman J, Luger T, Paus R, Solomon S (2000b) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020
27. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE et al. (2001) Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15:1678-93
28. Slominski A, Zbytek B, Semak I, Sweatman T, Wortsman J (2005b) CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol 162:97-102
29. Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T et al. (2005a) CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab 288:E701-6
30. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004b) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84:1155-228
31. Sugama S, Kim Y, Baker H, Tinti C, Kim H, Joh TH et al. (2000) Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J Immunol 165:6287-92
32. Tringali G, Pozzoli G, Vairano M, Mores N, Preziosi P, Navarra P (2005) Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stess axis. J Neuroimmunol 160:61-7
33. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K et al. (1996) Cloning of the cDNA for human IFN γ- inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156:4274-9
34. Wakamatsu K, Graham A, Cook D, Thody AJ (1997) Characterization of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res 10:288-97
35. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J (1998) Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92:501-9
36. + T cells IL-4 and STAT6. Nat Immunol 1:132-7